Physician profile
Gillian Leeder
NPI 1003300138
$4,582.79
in general payments reported to CMS, 2019-2025
33 companies · $736 in 2025
The $736 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $338 · 2022: $982 · 2023: $1,635 · 2024: $891 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,262.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $907.31 | 2021-2023 | Interstim |
| Dendreon Pharmaceuticals LLC | $468.88 | 2022-2025 | Provenge |
| Sumitomo Pharma America, INC. | $437.57 | 2023-2025 | Orgovyx, Gemtesa |
| Novartis Pharmaceuticals Corporation | $392.51 | 2022-2025 | |
| Abbvie INC. | $340.48 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $247.99 | 2022-2025 | |
| Astellas Pharma US INC | $246.51 | 2021-2024 | Xtandi |
| Endo Pharmaceuticals INC. | $177.65 | 2021-2024 | Aveed, Xiaflex, Edex |
| Endo USA, INC. | $172.70 | 2024-2025 | Xiaflex, Aveed |
| Axonics, INC. | $137.35 | 2021-2023 | Axonics, Bulkamid |
| Boston Scientific Corporation | $111.81 | 2021-2025 | Axonics |
| Janssen Biotech, INC. | $102.60 | 2023 | Erleada |
| Bioprotect Medical, INC. | $96.46 | 2025 | Bioprotect Balloon Implant System |
| Telix Pharmaceuticals | $79.94 | 2023-2024 | Illuccix |
| Teleflex LLC | $74.05 | 2024 | Urolift |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $58.40 | 2023 | Keytruda, Lynparza, Welireg |
| Tolmar, INC. | $55.11 | 2023-2024 | |
| Myovant Sciences INC. | $52.70 | 2022 | |
| Sun Pharmaceutical Industries INC. | $49.87 | 2022-2023 | Yonsa |
| Progenics Pharmaceuticals, INC. | $43.06 | 2024-2025 | |
| Urogen Pharma, INC. | $40.93 | 2023-2024 | |
| Tolmar Pharmaceuticals, INC. | $37.92 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $34.16 | 2024 | Myrisk |
| Procept Biorobotics Corporation | $28.00 | 2024 | Aquabeam System |
| Philips North America LLC | $27.63 | 2021 | |
| Coloplast Corp | $27.09 | 2024 | |
| Jazz Pharmaceuticals INC. | $23.40 | 2021 | |
| Urovant Sciences INC | $22.75 | 2022 | |
| Azurity Pharmaceuticals, INC. | $21.65 | 2025 | Azmiro |
| Blue Earth Diagnostics | $20.15 | 2022 | |
| Antares Pharma, INC. | $19.65 | 2025 | Xyosted |
| Astrazeneca Pharmaceuticals Lp | $14.80 | 2023 | Lynparza |
| Dentsply Ih INC. | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gillian Leeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.